
Enveric Biosciences, Inc.
ENVBNasdaqCIK 890821HealthcareFiscal year ends Dec 31
Reports and events: 398 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-03-3116:43 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-008510 |
| 2022-03-1514:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-006846 |
| 2022-03-0117:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-005767 |
| 2022-02-1816:15 ET | 8-K | 3.01 Delisting notice | 0001493152-22-004959 |
| 2022-02-1511:07 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-004649 |
| 2022-02-0912:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-003573 |
| 2022-01-1915:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-001580 |
| 2021-12-3017:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-032874 |
| 2021-11-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-21-029223 |
| 2021-11-1521:13 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-028263 |
| 2021-10-0515:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-024612 |
| 2021-10-0507:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-024572 |
| 2021-09-1707:00 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-022964 |
| 2021-09-1416:57 ET | 8-K | 5.07 Shareholder vote results | 0001493152-21-022698 |
| 2021-09-0317:26 ET | 8-K | 8.01 Other events | 0001493152-21-022044 |
| 2021-08-1316:31 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001493152-21-019738 |
| 2021-07-0816:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-016459 |
| 2021-07-0616:07 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001493152-21-016224 |
| 2021-06-2916:05 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-21-015539 |
| 2021-06-2806:14 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-21-015334 |
| 2021-06-0814:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-013803 |
| 2021-05-2417:23 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-012752 |
| 2021-05-2016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-012349 |
| 2021-05-1717:15 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001493152-21-011946 |
| 2021-05-1416:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-21-011500 |
| 2021-04-1312:17 ET | DEF 14A | Proxy statementPeriod 2021-04-13 | 0001493152-21-008618 |
| 2021-04-1212:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-21-008506 |
| 2021-04-0117:17 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001493152-21-007757 |
| 2021-04-0108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-21-007644 |
| 2021-03-2316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-21-006621 |
| 2021-03-1116:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-005817 |
| 2021-02-2616:19 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-004933 |
| 2021-02-1216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-003633 |
| 2021-02-1116:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-003373 |
| 2021-02-0909:16 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-21-003025 |
| 2021-01-1516:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-001161 |
| 2021-01-1317:25 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-21-000971 |
| 2021-01-1209:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-000824 |
| 2021-01-1107:42 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-21-000698 |
| 2021-01-0617:11 ET | 8-K | 3.01 Delisting notice; 4.01 Change of auditor; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-000337 |
| 2021-01-0617:10 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-000336 |
| 2020-12-2910:07 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-024425 |
| 2020-12-2317:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-024265 |
| 2020-12-1817:42 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-20-023958 |
| 2020-12-1516:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-20-023638 |
| 2020-11-1606:31 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001493152-20-021409 |
| 2020-11-0409:30 ET | DEF 14A | Proxy statementPeriod 2020-11-04 | 0001493152-20-020444 |
| 2020-09-1608:38 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-20-017871 |
| 2020-09-1108:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-20-017593 |
| 2020-08-1416:22 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001493152-20-015855 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.